MiBoFlo Thermoelectric Technology

MiBo Thermoflo is a medical device designed for addressing Meibomian Gland Dsyfunction (MGD).

Immediate Relief

MiBoFlo® gently heats the meibomian glands, providing patients with same-day comfort.

No Disposables

Increase profitability by eliminating recurring disposable expenses from every treatment.

MiBo Thermoflo — Meibomian Duct Therapy

Clinically Validated

Peer-reviewed clinical studies demonstrate MiBoFlo®'s effectiveness in treating MGD and evaporative dry eye, with measurable clinical improvements and high patient satisfaction.

maximize existing technology

Clinical studies show improved treatment outcomes with MiBoFlo® as a standalone treatment and in combination with other dry eye treatments.

Reduce Doctor Time

Delegate MiBoFlo treatments to trained staff to maximize doctor time.

About

Founded in 2012, MiBo Medical Group is a privately owned medical device company. Our flagship device, MiBo Thermoflo® is made in Texas, U.S.A.

Our Mission

We empower practices to transform dry eye treatment into a premium Dry Eye Spa experience that patients enjoy.

Doctor Testimonials

What practices are seeing

"We are enjoying the growth in our MGD practice, including spontaneous statements of patient satisfaction with the MiBo device."

John D. Sheppard MD, MMSC
Virginia Eye Consultants

"The MiBoFlo provides almost immediate improvements to my meibomian gland disease and lipid deficient dry eye patients."​

Thomas P. Kislan OD
Hazleton Eye Specialist

"My patients are seeing results after the first treatment and they're happy to schedule their next appointment. MiBo has no click fees and it's well-received by patients and staff."

James S. Lewis MD
Dry Eye Philadelphia

"My early results are very encouraging that the MiBoFlo will be a powerful device to treat meibomian gland dysfunction"

Harvey Fishman OD, PhD
Fishman Vision

Trusted in Academia

Universities Using MiBo

Get in Touch

Connect with us

(669) 799-2020
info@mibomedicalgroup.com

Follow us on social media for exclusive content.